|
|
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.China |
First Approval Date01 Jan 1998 |
100 Clinical Results associated with PBPs x CYP2C9
100 Translational Medicine associated with PBPs x CYP2C9
0 Patents (Medical) associated with PBPs x CYP2C9